FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071014 [Registered on: 22/07/2024] Trial Registered Prospectively
Last Modified On: 10/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical trial to compare the effects of two drugs, Ceftriaxone and Benzathine Penicillin in the treatment of Early stage of the sexually transmitted disease, Syphilis 
Scientific Title of Study   A comparative study of Injection Benzathine Penicillin and Injection Ceftriaxone in the management of Early Syphilis 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Briswin Jino B G 
Designation  Junior Resident 
Affiliation  Government Tirunelveli Medical College 
Address  Department of Dermatology, Venereology and Leprosy, Government Tirunelveli Medical College Hospital, Tirunelveli.

Tirunelveli
TAMIL NADU
627011
India 
Phone  9489857660  
Fax    
Email  jino.jinobj@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. M. Selvakumar 
Designation  Associate Professor 
Affiliation  Government Tirunelveli Medical College 
Address  Department of Dermatology, Venereology and Leprosy, Government Tirunelveli Medical College Hospital, Tirunelveli.
Department of Dermatology, Venereology and Leprosy, Government Tirunelveli Medical College Hospital, Tirunelveli.
Tirunelveli
TAMIL NADU
627011
India 
Phone  9894308296  
Fax    
Email  drmselvakumar71@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Briswin Jino B G 
Designation  Junior Resident 
Affiliation  Government Tirunelveli Medical College 
Address  Department of Dermatology, Venereology and Leprosy, Government Tirunelveli Medical College Hospital, Tirunelveli.


TAMIL NADU
627011
India 
Phone  9489857660  
Fax    
Email  jino.jinobj@gmail.com  
 
Source of Monetary or Material Support  
Department of Dermatology, Venereology and Leprosy, Government Tirunelveli Medical College, Tirunelveli - 627011, Tamilnadu, India 
 
Primary Sponsor  
Name  Government Tirunelveli Medical College 
Address  Department of Dermatology, Venereology and Leprosy, Government Tirunelveli Medical college Hospital, Tirunelveli - 627011 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Briswin Jino BG  Government Tirunelveli Medical College  Room No 41, Venereology OPD, Department of Dermatology, Venereology and Leprosy
Tirunelveli
TAMIL NADU 
9489857660

jino.jinobj@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Post Graduate Scientific Advisory Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: A519||Early syphilis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Injection Benzathine Penicillin  Single Dose of Injection Benzathine Penicillin 2.4 Million Units deep Intramuscularly 
Intervention  Injection Ceftriaxone  Injection Ceftriaxone 1 gram Intravenously for 10 days 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  All patients who present in STD Clinics with untreated Early syphilis (Includes Primary, Secondary and Early latent syphilis).

Operational definition for Early syphilis – 1 year from the primary lesion(chancre) or if there is no primary chancre 1 year from the date of last contact with REACTIVE RPR & Confirmed by POSITIVE TPHA
 
 
ExclusionCriteria 
Details  1. Positive skin-test reaction to penicillin antigen and ceftriaxone antigen
2. History of penicillin and ceftriaxone allergy
3. Patients who have received any other antibiotics before initiation of treatment
4. Patients with Late latent syphilis and Tertiary syphilis
 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Serological response as defined as a four fold decrease in the initial RPR titre within 6 months of treatment  Serological response as defined as a four fold decrease in the initial RPR titre within 6 months of treatment 
 
Secondary Outcome  
Outcome  TimePoints 
Comparing the time taken for RPR to fall in both groups and to monitor for Adverse events if any in both groups  6 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   22/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a randomized controlled trial which aims at comparing the efficacy Injection Benzathine Penicillin and Injection Ceftriaxone in the management of Early syphilis. Several studies have shown the efficacy of Injection Ceftriaxone in the management of Neurosyphilis and Primary and secondary syphilis in special populations like those infected with HIV and pregnant women. But there are limited studies available supporting Injection ceftriaxone as an alternative treatment for Early syphilis without HIV infection. The outcome will be measured by the fourfold decline in RPR titre from the baseline. Patients who have treatment failure with Injection Ceftriaxone will be given the standard dose of Injection Benzathine Penicillin. 
Close